# Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers

> **NCT01893528** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 49 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** REGN2009
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01893528
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893528, "Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01893528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*